Send us a text

Envoy’s CEO Brent Lucas and Envoy’s CFO David Wells join WTR’s Thierry Wuilloud and Tim Regan to discuss the company’s Acclaim cochlear implant.  The Acclaim has two key differentiating characteristics compared to the current market leading cochlear implants: First, it uses the ear to capture sound, unlike the current standard devices which capture sound externally behind the ear.  Second, the device is completely implanted, unlike the other devices which are partially implanted, with elements resting on the skull, typically above the ear, and posing associated challenges (think Lasik vs contact lenses or glasses).  Brent and David discuss the Acclaim, its modus operandi, patient profiles, reimbursement issues, approval process, and the company’s financial position and needs to shepherd the product through approval and commercialization.